The 52-Week Low Club (C)(MBI)(RAD)
Rite Aid Corporation (RAD) Ugly earnings. No turnaround here. Falls to $2.71 from 52-week high of $6.74. MBIA (MBI) Concerns about CDOs being insured here. Falls to $18.84 from 52-week high of $76.02. SLM (SLM) Still falling after comments about…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Rite Aid Corporation (RAD) Ugly earnings. No turnaround here. Falls to $2.71 from 52-week high of $6.74.
MBIA (MBI) Concerns about CDOs being insured here. Falls to $18.84 from 52-week high of $76.02.
SLM (SLM) Still falling after comments about tough 2008 and possible dividend cut. Down to $19.84 from 52-week high of $58.
Altus Pharmaceuticals (ALTU) Partnership with Genentech (DNA) broken off. Sells off to $4.80 from 52-week high of $20.50.
Amicus Therapeutics (FOLD) Wall St. views new drug as less than competitive to current offerings. Shares drop to $9.20 from 52-week high of $18.22.
Array Biopharma (ARRY) Clinical trial fails. Drops to $7.81 from 52-week high of $14.59
Citigroup (C) Fresh concerns about mortgage risks. Drops to $29.34 from 52-week high of $57.
Douglas A. McIntyre
Douglas A. McIntyre
Contact [email protected] for any questions or corrections.